Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters










Publication year range
1.
Cancer Lett ; 168(2): 141-4, 2001 Jul 26.
Article in English | MEDLINE | ID: mdl-11403918

ABSTRACT

XK469 (2-[4-(7-chloro-2-quinoxalinyloxy) phenoxy]propionic acid) is a new anti-tumor agent with substantial activity against several drug-resistant cell lines. Using murine leukemia L1210 cells in culture, we found the chiral R(+) form of XK469 to be substantially more cytotoxic than the S(-) form, while the herbicide analog 'Assure' was essentially inactive. The cytotoxic response to these agents was accompanied by apoptosis, and was found to be correlated with drug binding to the peripheral benzodiazepine receptor in cell culture, suggesting that receptor binding may be a factor in drug-induced cytotoxicity.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Quinoxalines/pharmacology , Receptors, GABA-A/metabolism , Animals , Antineoplastic Agents/metabolism , Apoptosis/physiology , Binding, Competitive , Cell Nucleus/drug effects , GABA-A Receptor Agonists , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Isoquinolines/metabolism , Isoquinolines/pharmacology , Leukemia L1210/drug therapy , Leukemia L1210/pathology , Membrane Potentials/drug effects , Mice , Mitochondria/drug effects , Mitochondria/physiology , Quinoxalines/metabolism , Staurosporine/pharmacology , Stereoisomerism
2.
J Med Chem ; 44(11): 1758-76, 2001 May 24.
Article in English | MEDLINE | ID: mdl-11356111

ABSTRACT

2-(4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469) is among the most highly and broadly active antitumor agents to have been evaluated in our laboratories and is currently scheduled to enter clinical trials in 2001. The mechanism or mechanisms of action of XK469 remain to be elaborated. Accordingly, an effort was initiated to establish a pharmacophore hypothesis to delineate the requirements of the active site, via a comprehensive program of synthesis of analogues of XK469 and evaluation of the effects of structural modification(s) on solid tumor activity. The strategy formulated chose to dissect the two-dimensional parent structure into three regions-I, ring A of quinoxaline; II, the hydroquinone connector linkage; and III, the lactic acid moiety-to determine the resultant in vitro and in vivo effects of chemical alterations in each region. Neither the A-ring unsubstituted nor the B-ring 3-chloro-regioisomer of XK469 showed antitumor activity. The modulating antitumor effect(s) of substituents of differing electronegativities, located at the several sites comprising the A-ring of region I, were next ascertained. Thus, a halogen substituent, located at the 7-position of a 2-(4-[(2-quinoxalinyl)oxy]phenoxy)propionic acid, generated the most highly and broadly active antitumor agents. A methyl, methoxy, or an azido substituent at this site generated a much less active structure, whereas 5-, 6-, 8-chloro-, 6-, 7-nitro, and 7-amino derivatives all proved to be essentially inactive. When the connector linkage (region II) of 1 was changed from that of a hydroquinone to either a resorcinol or a catechol derivative, all antitumor activity was lost. Of the carboxylic acid derivatives of XK469 (region III), i.e., CONH2, CONHCH3, CON(CH3)2, CONHOH, CONHNH2, CN, or CN4H (tetrazole), only the monomethyl- and N,N-dimethylamides proved to be active.


Subject(s)
Antineoplastic Agents/chemical synthesis , Quinoxalines/chemical synthesis , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Drug Design , Drug Screening Assays, Antitumor , Humans , Mice , Quinoxalines/chemistry , Quinoxalines/pharmacology , Stereoisomerism , Structure-Activity Relationship , Transplantation, Heterologous , Tumor Cells, Cultured
3.
Invest New Drugs ; 17(1): 17-27, 1999.
Article in English | MEDLINE | ID: mdl-10555119

ABSTRACT

A highly active and broadly active thioxanthone has been identified: N-[[1-[[2-(Diethylamino)ethyl]amino]-7-methoxy-9-oxo-9H-thioxanthen++ +-4-yl] methylformamide (SR271425, BCN326862, WIN71425). In preclinical testing against a variety of subcutaneously growing solid tumors, the following %T/C and Log10 tumor cell kill (LK) values were obtained: Panc-03 T/C = 0, 5/5 cures; Colon-38 (adv. stage) T/C = 0, 3/5 cures, 4.9 LK; Mam-16/C T/C = 0, 3.5 LK; Mam-17/0 T/C = 0, 2.8 LK; Colon-26 T/C = 0, 1/5 cures, 3.2 LK; Colon-51 T/C = 0, 2.7 LK; Panc-02 T/C = 0, 3.1 LK; B16 Melanoma T/C = 13%, 4.0 LK; Squamous Lung-LC12 (adv. stage) T/C = 14%, 4.9 LK; BG-1 human ovarian T/C = 16%, 1.3 LK; WSU-Brl human breast T/C = 25%, 0.8 LK. The agent was modestly active against doxorubicin (Adr)-resistant solid tumors: Mam-17/AdrT/C =23%, 0.8 LK; and Mam-16/C/Adr T/C = 25%, 1.0 LK, but retained substantial activity against a taxol-resistant tumor: Mam-16/C/taxol T/C = 3%, 2.4 LK. SR271425 was highly active against IV implanted leukemias, L1210 6.3 LK and AML1498 5.3 LK. The agent was equally active both by the IV and oral routes of administration, although requiring approximately 30% higher dose by the oral route. Based on its preclinical antitumor profile, it may be appropriate to evaluate SR271425 in clinical trials.


Subject(s)
Antineoplastic Agents/therapeutic use , Thioxanthenes/therapeutic use , Animals , Antineoplastic Agents/chemistry , Doxorubicin/therapeutic use , Drug Resistance, Multiple/physiology , Drug Resistance, Neoplasm/physiology , Drug Screening Assays, Antitumor , Drug Stability , Humans , Mice , Mice, Inbred ICR , Mice, Transgenic , Neoplasm Transplantation , Paclitaxel/therapeutic use , Thioxanthenes/chemistry
4.
Invest New Drugs ; 16(2): 129-39, 1998.
Article in English | MEDLINE | ID: mdl-9848576

ABSTRACT

A series of quinoxaline analogs of the herbicide Assure was found to have selective cytotoxicity for solid tumors of mice in a disk-diffusion-soft-agar-colony-formation-assay compared to L1210 leukemia. Four agents without selective cytotoxicity and 14 agents with selective cytotoxicity were evaluated in vivo for activity against a solid tumor. The four agents without selective cytotoxicity in the disk-assay were inactive in vivo (T/C > 42%). Thirteen of the fourteen agents with selectivity in the disk-assay were active in vivo (T/C < 42%). Five of the agents had curative activity. These five agents had a halogen (F, Cl, Br) in the 7-position (whereas Assure had a CI in the 6 position). All agents with curative activity were either a carboxylic acid, or a derivative thereof, whereas Assure is the ethyl ester of the carboxylic acid. All other structural features were identical between Assure and the curative agents. Assure had no selective cytotoxicity for solid tumors in the disk-assay, and was devoid of antitumor activity. The analog XK469 is in clinical development.


Subject(s)
Antineoplastic Agents/pharmacology , Quinoxalines/pharmacology , Animals , Drug Screening Assays, Antitumor , Female , Male , Mice , Molecular Structure
5.
J Steroid Biochem Mol Biol ; 50(1-2): 75-84, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8049136

ABSTRACT

The effect of the modification of the 9-11 positions on the skeletal conformation of estradiol (E2) has been analyzed by X-ray crystallography and MM2 molecular mechanics. The 11 beta-hydroxyl and 11-keto analogs of E2 maintained ring conformations which were similar to the natural hormone (E2). Introduction of a double bond at position 9-11 induced a flattening of the entire steroid molecule. An 11 alpha-hydroxyl group brought about significant changes in the alicyclic rings of E2. 9 beta-Estradiol and 11-keto-9 beta-estradiol formed ring conformations which were significantly bent from E2 (below the plane of the A-ring). Examination of the affinity of these C-ring analogs of E2 for the human estrogen receptor has shown extreme variations. A hydroxyl group placed either alpha or beta at the 11-position yielded ligands with vastly different and reduced affinities for the receptor. The low affinity of 11 alpha-hydroxyestradiol (1/300th of E2) may be due to the drastic structural change induced in the alicyclic portion of the molecule, as well as, to the steric or electrostatic effects of the alpha-hydroxyl group upon the receptor protein. An 11 beta-hydroxyl group diminished the receptor binding to 1/60th that of E2 without alicyclic ring distortions, whereas a 9-11 unsaturation reduced the binding to 1/5th although this steroid displayed a flattening of rings B, C, and D. The 11-keto function, which had little effect on the conformation of the estrogen nucleus, reduced the affinity of this ligand to 1/1000th that of E2. The negative bend at the C-ring of 11-keto-9 beta-estradiol and 9 beta-estradiol prevented these ligands from binding receptor. Some of the observed receptor interactions were related to structural alterations in the estrogen ring system induced by modifications on the 9-11 region.


Subject(s)
Estradiol/chemistry , Receptors, Estradiol/metabolism , Crystallography, X-Ray , Estradiol/analogs & derivatives , Estradiol/metabolism , Humans , Models, Molecular , Molecular Conformation , Molecular Structure
6.
J Med Chem ; 37(6): 781-6, 1994 Mar 18.
Article in English | MEDLINE | ID: mdl-8145227

ABSTRACT

The present study establishes correlations of in vivo growth inhibition of a solid tumor, pancreatic ductal adenocarcinoma (Panc03), of mice with the steric and electrostatic fields and the hydrophobic parameter log P of a series (32) of 1-[[2-(dialkylamino)alkyl]amino]- 9H-thioxanthen-9-ones by the 3D-QSAR method comparative molecular field analysis (CoMFA). The template molecular model was hycanthone methanesulfonate (19), the structure of which had been established previously by X-ray crystallography. The hycanthone base is protonated at the terminal nitrogen N(2), and an intramolecular hydrogen bond is present between the proximal nitrogen N(1) and carbonyl oxygen O(1) atoms. Crystallographic data also indicate a planar arrangement of bonds around N(1). However, the molecular geometry of 19, optimized by semiempirical molecular orbital methods (PM3, MNDO, AM1), showed the expected trigonal-pyramidal configuration for N(1). A comparison of MO and ab initio methods applied to a model compound, 1-amino-9H-thioxanthen-9-one, led to the selection of PM3 as the method for full geometry optimization of first the cationic and then the neutral forms of 1-32, whereas AM1 provided atomic charges for these same structures save those incorporating a sulfonamide moiety (5, 7, 20, 25, 26, 29, 31, and 32). Acceptable values for the latter were obtained from ab initio calculations. Structures were aligned by minimizing root-mean-square (rms) differences in the fitting of structures to 19 using the FIT option of SYBYL. An alternative strategy of alignment, steric and electrostatic alignment (SEAL), was invoked to provide a comparison of statistical data generated with the rms alignment. The rms-fit alignment of structures produced slightly better cross-validated and conventional r2 values than those generated with the SEAL method. In addition, the rms-fit data indicate that a shift in the lattice of one-half of its spacing has a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. Inclusion of log P in a CoMFA of the neutral structures effected a small (ca. 8-10%) but significant improvement in cross-validated r2 values. The relative contributions of the hydrophobic effects and the steric and electrostatic fields to the conventional r2 values were 16%, 42%, and 42%, respectively. By contrast, incorporation of frontier molecular orbital (HOMO and LUMO) energies or their gaps in the PLS analyses failed to enhance correlation coefficients derived for either the charged or uncharged compounds.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/therapeutic use , Pancreatic Ducts , Pancreatic Neoplasms/drug therapy , Thioxanthenes/pharmacology , Animals , Antineoplastic Agents/toxicity , Cell Line , Mice , Models, Molecular , Structure-Activity Relationship , Thioxanthenes/chemistry
7.
J Med Chem ; 36(23): 3511-6, 1993 Nov 12.
Article in English | MEDLINE | ID: mdl-8280289

ABSTRACT

In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to mouse leukemia L1210 cells. Comparative molecular field analysis (CoMFA) was applied to HCT-8 and L1210 growth inhibition assays (IC50s) of a series (44) of the pyrazoloacridine derivatives with the objective of predicting improved solid tumor selectivity. In the absence of crystallographic data, the 9-methoxy derivative (15), which is currently in clinical study, was selected as the template molecular model. Two different structural alignments were tested: an alignment of structures based on root mean square (RMS)-fitting of each structure to 15 was compared with an alternative strategy, steric and electrostatic alignment (SEAL). Somewhat better predictive cross-validation correlations (r2) were obtained with models based on RMS vis-à-vis SEAL alignment for both sets of assays. A large change in lattice spacing, e.g., 2 to 1 A, causes significant variations in the CoMFA results. A shift in the lattice of half of its spacing had a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. The relative contribution of steric and electrostatic fields to both models were about equal, underscoring the importance of both terms. Neither calculated log P nor HOMO and/or LUMO energies contribute to the model. Steric and electrostatic fields of the pyrazoloacridines are the sole relevant descriptors to the structure-activity (cross-validated and conventional) correlations obtained with the cytotoxic data for both the L1210 and HCT-8 cell lines. The cross-validated r2, derived from partial least-squares calculations, indicated considerable predictive capacity for growth inhibition of both the leukemia and solid-tumor data. Evidence for the predictive performance of the CoMFA-derived models is provided in the form of plots of actual vs predicted growth inhibition of L1210 and HCT-8 cells, respectively, by the pyrazoloacridines. The steric and electrostatic features of the QSAR are presented in the form of standard deviation coefficient contour maps of steric and electrostatic fields. The maps indicate that increases or decreases in steric bulk that would enhance growth inhibition of HCT-8 cells would likewise promote growth inhibition of L1210 cells. Contour maps generated to analyze the electrostatic field contributions of the pyrazoloacridines to growth inhibition provide an essentially similar set of results.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Acridines/therapeutic use , Adenocarcinoma/drug therapy , Antineoplastic Agents/pharmacology , Colonic Neoplasms/drug therapy , Leukemia L1210/drug therapy , Pyrazoles/therapeutic use , Acridines/chemistry , Animals , Electrochemistry , Humans , Intercalating Agents , Mice , Models, Molecular , Molecular Structure , Pyrazoles/chemistry , Structure-Activity Relationship , Tumor Cells, Cultured
9.
J Steroid Biochem ; 35(2): 219-29, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2308337

ABSTRACT

The effect of the position of the phenolic hydroxyl on the conformations of the three A-ring isomers of estradiol, namely, estra-1,3,5(10)-trien-1,17 beta-diol (10), estra-1,3,5(10)-trien-2,17 beta-diol (3), and estra-1,3,5(10)-trien-4,17 beta-diol (6), has been analyzed by X-ray crystallography. The results of these analyses were correlated with the absorptions of the angular methyl groups in the [1H]NMR spectra of these isomers and natural estradiol (E2). It was observed that the changes in chemical shift of protons at C18 corresponded to skeletal modifications in the steroid structure which changed the anisotropic effect of the hydroxyl group at C17. Examination of the affinity of these A-ring isomers of E2 for the estrogen receptor has shown the 2-hydroxylated isomer 3 to retain 1/5th the affinity of E2 for its binding protein. The 1- and 4-hydroxylated derivatives (10 and 6, respectively) bound to a much lesser extent. The receptor affinities of these estrogen analogues may be related to the angle between the 18-methyl and the 17 beta-hydroxyl groups (or the dihedral angle between the planar A-ring and the angular C18 methyl) as well as the position of the A-ring hydroxyl group.


Subject(s)
Estradiol/metabolism , Chemical Phenomena , Chemistry , Crystallography , Isomerism , Magnetic Resonance Spectroscopy , Molecular Conformation , Receptors, Estradiol/metabolism , X-Ray Diffraction
10.
J Med Chem ; 33(1): 258-63, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2153206

ABSTRACT

Oxygen-sulfur exchange at the C-4 carbonyl of several modified pyrimidine nucleosides, including 3'-azido-3'-deoxythymidine (AZT), is described in an effort to enhance the lipophilicity and, thereby, the delivery to the central nervous system of the sulfur analogues without compromising the anti-HIV activities of the parental structures. Preparation of 3'-azido-3'-deoxy-4-thiothymidine (3) proceeded from 4-thiothymidine (1) and utilized the same methodology developed for the initial synthesis of AZT. Thiation of 2',3'-didehydro-3'-deoxythymidine (4a) and 2',3'-didehydro-2',3'-dideoxyuridine (4c) was carried out with Lawesson's reagent on the corresponding 5'-O-benzoate esters, 4b and 4d, to give 5a and 5c, respectively. The latter, on alkaline hydrolysis, gave 2',3'-didehydro-3'-deoxy-4-thiothymidine (5b) and 2',3'-didehydro-2',3'-dideoxyuridine (5d), respectively. The same series of reactions were applied to the 5'-O-benzoate esters of 2',3'-dideoxyuridine (6a) and 3'-deoxythymidine (6b) to give 2',3'-dideoxy-4-thiouridine (7d) and 3'-deoxy-4-thiothymidine (7b), respectively. Characterization of the saturated and unsaturated thionucleosides included mass spectrometric studies. Under electron impact conditions, the thiated analogues gave more intense parent ions than the corresponding oxygen precursors. The lipophilicity of thymidine and the 3'-deoxythymidine derivatives are enhanced significantly, as indicated, by increases in corresponding P values (1-octanol-0.1 M sodium phosphate) upon replacement of the 4-carbonyl oxygens by sulfur. Compounds 5b, 5d, 7b, and 7d were evaluated for their effects on HIV-induced cytopathogenicity of MT-2 and CEM cells. Only 5b and 7b were moderately active in protecting both cell lines against the cytolytic effect of HIV. The inhibitory effects of analogues 5b, 5d, 7b, and 7d on thymidine phosphorylation by rabbit thymus thymidine kinase were evaluated. Only 3 showed moderate affinity (Ki = 54 microM) for the enzyme. The generally weak anti-HIV activities of the remaining thio analogues are consistent with correspondingly low susceptibilities to thymidine kinase phosphorylation as estimated from the respective Ki values of the synthetic nucleosides. However, the phosphorylation of the 5'-monophosphate derivatives to their respective 5'-triphosphates must also be considered in connection with the weak in vitro anti-HIV effects of these thiated compounds.


Subject(s)
AIDS Dementia Complex/drug therapy , Antiviral Agents , Dideoxynucleosides/pharmacology , Pyrimidine Nucleosides/pharmacology , Zidovudine/analogs & derivatives , AIDS Dementia Complex/prevention & control , Animals , Cell Line , Chemical Phenomena , Chemistry , Chemistry, Physical , Cytopathogenic Effect, Viral/drug effects , Dideoxynucleosides/chemical synthesis , Dideoxynucleosides/therapeutic use , HIV/drug effects , HIV/physiology , Humans , Kinetics , Molecular Structure , Phosphorylation , Pyrimidine Nucleosides/chemical synthesis , Pyrimidine Nucleosides/therapeutic use , Rabbits , Stavudine , T-Lymphocytes/microbiology , Thymidine Kinase/metabolism , Thymus Gland/enzymology , Zidovudine/chemical synthesis , Zidovudine/pharmacology , Zidovudine/therapeutic use
11.
Invest New Drugs ; 7(1): 51-7, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2661483

ABSTRACT

3'-Azido-2'3'-dideoxythymidine (AZT), a thymidine analogue with potent antiretroviral activity against human immunodeficiency virus (HIV) in vitro, has been shown to confer a clinical benefit in patients with advanced acquired immune deficiency syndrome (AIDS). Other 2',3'-dideoxynucleosides, e.g., 2',3'-dideoxy-cytidine and 2',3'-dideoxyadenosine, block the infectivity of HIV against helper/inducer T cells in vitro and protect the cell against the cytopathic effect of the virus. The majority of these antiretroviral agents were synthesized more than twenty years ago as analogues of physiologically important deoxynucleosides in the quest of a more effective cancer chemotherapy. None of the synthetic analogues manifested significant activity when screened against L1210 leukemia in BDF mice despite the fact that the phosphorylation reactions, crucial to the activation of the 2',3'-dideoxynucleosides, are catalyzed by kinases of appropriate target cells. However, the 2',3'-dideoxynucleoside triphosphates, relative to corresponding deoxynucleotides, have a reduced affinity for DNA polymerase alpha, an enzyme that has key DNA synthetic and repair functions in the life of a cell. In contrast, HIV reverse transcriptase, like host cellular DNA polymerase beta (a repair enzyme) and gamma (a mitochondrial enzyme), is much more susceptible to the inhibitory effects of the dideoxynucleotides. This would explain the activity of the fradulent nucleotides at low concentrations against pathogenic retroviruses vis à vis the low cytoxic activity observed with these agents as anti-leukemia drugs.


Subject(s)
Antimetabolites/chemical synthesis , Dideoxynucleosides/chemical synthesis , Animals , Antimetabolites/pharmacology , Dideoxynucleosides/pharmacology , Drug Design , Humans
12.
J Med Chem ; 32(3): 622-5, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2918510

ABSTRACT

The present study evaluates the utility of the dihydropyridine in equilibrium pyridinium salt redox system for the specific delivery and sustained release of a model 2',3'-dideoxynucleoside to the brain of mice as the initial effort in a search for agents that may prove effective in reversing the complicating neurological disorders of AIDS. The unsaturated nucleoside 2',3'-didehydro-2',3'-dideoxythymidine (1), which is effective in protecting ATH8 cells against the cytopathogenicity of HIV-1, was converted to the corresponding N-methyl-1,4-dihydronicotinate derivative, 4, in three steps. The 5'-O-nicotinate ester, 2, obtained by reaction of 1 with nicotinyl chloride, was converted in quantitative yield to the N-methylpyridinium salt 3 on treatment with MeI in acetone. Reduction of the latter with Na2S2O4 gave 4 in 50% yield. Pseudo-first-order rate constants for the oxidation of 4 to 3 were observed in plasma (k = 3.54 x 10(-5) s-1) and in homogenates of mouse liver (k = 9.2 x 10(-5) s-1) and brain (k = 8.85 x 10(-5) s-1). None of the chemical delivery system 4 could be detected in the brain of female BDF/1 mice at 1 h postinjection. The peak level of 3 in the brain occurred at 3 h with a half-life of 25 h. Both 1 and N-methylnicotinic acid (trigonelline, 5) were readily identified by HPLC in a brain homogenate derived from mice injected (25 mg/kg) with 4. TLC showed a low level penetration of mouse brain by 1 (0.44 microgram/g wet tissue) following injection of the corresponding labeled [methyl-3H]-2',3'-unsaturated nucleoside (25 mg/kg). The data indicate that 4 crosses the blood-brain barrier to be oxidized by cerebral tissue to the ionic structure 3, which is "locked therein". The sustained local release of a 2',3'-dideoxynucleoside, such as 1, from a chemical delivery system (4) represents a potentially useful approach to the treatment of AIDS dementia complex.


Subject(s)
Dideoxynucleosides/chemical synthesis , Dihydropyridines/chemical synthesis , Animals , Blood-Brain Barrier , Brain/metabolism , Chemical Phenomena , Chemistry , Delayed-Action Preparations , Dideoxynucleosides/pharmacokinetics , Dihydropyridines/pharmacokinetics , Drug Carriers/chemical synthesis , Female , Liver/metabolism , Mice , Oxidation-Reduction
13.
Cancer Res ; 47(17): 4623-9, 1987 Sep 01.
Article in English | MEDLINE | ID: mdl-3040228

ABSTRACT

A-ring substituted estrogens have been examined as growth inhibitors of the hormone dependent MXT murine mammary tumor. Certain of these estrogen analogues inhibited the growth of newly implanted as well as established MXT tumors when administered either by s.c. or i.p. injections or by intubation. These compounds were nontoxic over a broad range of active levels. Amino and nitro groups, introduced at position-4 of estrone 3-methyl ether were particularly carcinostatic, a property not shared by 4-bromoestrone 3-methyl ether. In addition tumor inhibition was greatly diminished by placing the nitro group at the other ortho position (i.e., carbon-2). Evidence indicates that the A-ring substituted estrogens may function as growth inhibitors via the estrogen receptor mechanism in the case of 4-nitro- and 4-aminoestrone. The 3-methyl ethers of these compounds also blocked tumor growth, possibly through in vivo dealkylation leading to the free phenolic A-ring substituted estrogens. On the other hand, A-ring substituted 3-deoxyestrogens (particularly 4-nitro- and 4-aminoestratrien-17 beta-ol), which do not bind to receptor, were also excellent inhibitors of hormone dependent MXT breast tumors and therefore must express their activity by mechanisms other than that mediated by receptor. The A-ring substituted estrogens are unlike tamoxifen and diethylstilbestrol which (a) display toxicity at optimum inhibitory doses and (b) are inactive or marginally active in rodent breast cancer models.


Subject(s)
Carcinoma, Intraductal, Noninfiltrating/drug therapy , Estrogens/pharmacology , Mammary Neoplasms, Experimental/drug therapy , Animals , DNA/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Neoplasm Transplantation , Neoplasms, Hormone-Dependent/drug therapy , Receptors, Estrogen/drug effects , Structure-Activity Relationship
14.
J Steroid Biochem ; 25(6): 973-9, 1986 Dec.
Article in English | MEDLINE | ID: mdl-2948075

ABSTRACT

Steroid alcohol sulfotransferase (SAS) has been isolated from the cytosol of a human breast carcinoma cell line, MCF-7. This enzyme from Sephadex G-200 chromatography displayed a mol. wt of 118 KDa. The conditions for optimal enzymic activity of SAS were determined to be 20 min incubations at 45 degrees C in 0.2 M Tris buffer (pH 7.5) containing 0.06 M Mg2+. Chromatofocusing chromatography also yielded a single peak of SAS with a pI of 5.8. Results from the incubations of a series of androstane analogues revealed that SAS required a 3 beta-hydroxyl on a steroid with the trans bridge between the A and B rings. Neither the 3 beta-allylic hydroxyl group nor the A-ring phenolic 3-hydroxyl accepted the sulfate group from 3'-phosphoadenosine-5'-phosphosulfate. D-ring beta-hydroxyl groups were tolerated by the enzyme, however, alpha-hydroxyl groups on the D-ring appeared to interfere with the reaction. Sulfurylation of steroids by SAS was related inversely to the sum of the displacements of the 3-hydroxyl plus that of the 17-hydroxyl groups relative to the plane of symmetry of the dehydroepiandrosterone nucleus. This enzyme was also capable of sulfurylating short chain aliphatic alcohols, although at greatly reduced rates. 3 beta-Chloro-5-androstene-17-one and 2-nitroestradiol. 17 beta proved to be the best inhibitors of SAS.


Subject(s)
Breast Neoplasms/enzymology , Sulfotransferases , Sulfurtransferases/metabolism , Cell Line , Chemical Phenomena , Chemistry , Cytosol/enzymology , Dehydroepiandrosterone/analogs & derivatives , Dehydroepiandrosterone/metabolism , Humans , Kinetics , Structure-Activity Relationship , Substrate Specificity , Sulfates/metabolism , Sulfurtransferases/antagonists & inhibitors , Sulfurtransferases/isolation & purification
15.
J Med Chem ; 29(5): 692-8, 1986 May.
Article in English | MEDLINE | ID: mdl-3457954

ABSTRACT

Hormone-responsive rat and human mammary tumor, unlike normal epithelium, actively sulfoconjugates estrogens. The title compounds (9-11) were synthesized in search of specific inhibitors of estrogen sulfotransferase as a possible means of developing effective chemotherapeutic agents for treatment of hormone-dependent human mammary cancer. 4-Nitroestrone 3-triflate (7a) was converted to the corresponding estradiol derivative (8a) in 93% yield by reduction with NaBH4 under phase-transfer conditions. Catalytic reduction (10% Pd/C) of the latter gave 4-aminoestra-1,3,5(10)-trien-17 beta-ol (9a) in 77% yield. These same reactions were applied consecutively to 4-nitroestrone 3-nonaflate (7b) to give 9a in 56% overall yield. The amino steroid (9a) was converted to 4-fluoroestra-1,3,5(10)-trien-17 beta-ol (10a) via a Balz-Schiemann reaction, in 17% overall yield. Successive NaBH4 and (10% Pd/C) catalytic reductions of 4-fluoroestrone 3-O-(1-phenyl-1H-tetrazol-5-yl) ether (2b) provided a less satisfactory route to 10a. MCPBA oxidation of 9a gave 4-nitroestra-1,3,5(10)-trien-17 beta-ol (11a) in 56% yield. The same series of reactions were applied to 2-nitroestrone 3-triflate (7c) to give 2-amino- (9b), 2-fluoro- (10b), and 2-nitro- (11b) estra-1,3,5(10)-trien-17-ols in comparable yields. Substitution in the A ring results in improved inhibition of porcine endometrial sulfotransferase sulfoconjugation of estradiol relative to estra-1,3,5(10)-trien-17 beta-ol (4a). Moreover, electronegative substitution at C-4 of 4a is more effective than at C-2. In particular, the Ki (2.43 +/- 0.16 microM) of 11a is sixfold smaller than that of the unsubstituted steroid (4a).


Subject(s)
Estriol/analogs & derivatives , Estrogens/metabolism , Sulfotransferases , Sulfur/metabolism , Sulfurtransferases/antagonists & inhibitors , Animals , Estriol/pharmacology , Female , Swine
16.
Cancer Res ; 43(6): 2611-7, 1983 Jun.
Article in English | MEDLINE | ID: mdl-6406049

ABSTRACT

4-Nitroestrone 3-methyl ether has been shown to be an effective growth inhibitor of certain dimethylbenz(a)anthracene-induced rat mammary tumors in intact or ovariectomized rats. When administered at optimum levels (24 mg/kg daily), this A-ring-substituted estrone displayed no toxicity, slight estrogenicity, and an antitumor activity which was comparable to that of tamoxifen and nafoxidine and was surpassed only by ovariectomy or pharmacological doses of 17 beta-estradiol 3-benzoate. In addition, the appearance of mammary tumors was prevented when this estrogen derivative was administered to rats just prior to or after dimethylbenz(a)anthracene intubation. Unique to the action of the methyl ether of 4-nitroestrone on mammary tumors was the destruction of adenocarcinomas while permitting the appearance of fibroadenomas. Systemically, 4-nitroestrone 3-methyl ether brought about focal atrophy within the pituitary and ovaries while causing moderate hypertrophy of the uterus. Plasma prolactin was unaffected.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene , Benz(a)Anthracenes , Estrone/analogs & derivatives , Mammary Neoplasms, Experimental/chemically induced , Animals , Castration , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Estrone/pharmacology , Female , Ovary/drug effects , Pituitary Gland/drug effects , Rats , Rats, Inbred Strains , Uterus/drug effects
19.
Drug Metab Dispos ; 8(2): 77-83, 1980.
Article in English | MEDLINE | ID: mdl-6103792

ABSTRACT

Identification of low levels of a metabolite of unaltered skeletal structure, 1-chloro-3-ethynylpent-1-en-3,4-diol (VII), detected in biological specimens of both nonfatal and fatal poisonings with DL-1-chloro-3-ethylpent-1-en-4-yn-3-ol (ethchlorvynol, la), has been achieved by high-resolution GC/MS. Corroborative evidence for the assigned structure (VII) was provided by synthesis, the design of which included as a central objective, concurrent access to 1-chloro-3-ethynyl-3,4-epoxy-1-pentene (VI), the putative direct precursor of VII. The diastereomeric epoxide mixture (VI) is mutagenic toward Escherichia coli WP2 try-hcr-, a UV-deficient repair strain. By contrast, neither Ia, VI, nor VII proved to be mutagenic toward Salmonella typhimurium (TA98, TA100, TA1535, and TA1539) with or without a liver postmitochondrial fraction. However, the epoxides (VI) proved cytotoxic to, for example, TA100, which apparently overlies its potency as a mutagen. The cytotoxicity of VI was also apparent in an in vitro culture system.


Subject(s)
Ethchlorvynol/metabolism , Cell Division/drug effects , Chemical Phenomena , Chemistry , Ethchlorvynol/adverse effects , Humans , Mutagens , Salmonella typhimurium/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...